标题
Liquid biopsy: a step forward towards precision medicine in urologic malignancies
作者
关键词
Precision medicine, Personalized medicine, Kidney cancer, Bladder cancer, Prostate cancer, Liquid biopsy, Cell-free DNA, Circulating tumor DNA, Circulating tumor cells, Exosomse, Tumor markers, miRNAs, Long non-coding RNA, Biomarkers, Cancer treatment, Predictive markers
出版物
Molecular Cancer
Volume 16, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-04-14
DOI
10.1186/s12943-017-0644-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer
- (2017) Nicholas J. Vogelzang et al. EUROPEAN UROLOGY
- AR-V7 Transcripts in Whole Blood RNA of Patients with Metastatic Castration Resistant Prostate Cancer Correlate with Response to Abiraterone Acetate
- (2017) Tilman Todenhöfer et al. JOURNAL OF UROLOGY
- Liquid biopsy: ready to guide therapy in advanced prostate cancer?
- (2016) Miriam Hegemann et al. BJU INTERNATIONAL
- Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
- (2016) Le Qu et al. CANCER CELL
- Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients
- (2016) A. Markou et al. CLINICAL CHEMISTRY
- Circulating Tumor DNA as a Cancer Biomarker: Fact or Fiction?
- (2016) F. Leung et al. CLINICAL CHEMISTRY
- Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection
- (2016) Hideo Sasaki et al. Clinical Genitourinary Cancer
- Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells
- (2016) Xing-dong Xiong et al. DRUG RESISTANCE UPDATES
- Inferring expressed genes by whole-genome sequencing of plasma DNA
- (2016) Peter Ulz et al. NATURE GENETICS
- Inter-Individual Differences in RNA Levels in Human Peripheral Blood
- (2016) Piotr Chomczynski et al. PLoS One
- Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
- (2016) F. Scherer et al. Science Translational Medicine
- Urinary carbonic anhydrase IX splicing messenger RNA variants in urogenital cancers
- (2016) Francesca Malentacchi et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
- (2016) Peter Ulz et al. Nature Communications
- A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls
- (2016) Y Wu et al. Oncogenesis
- A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy
- (2016) James McKiernan et al. JAMA Oncology
- Circulating biomarkers to monitor cancer progression and treatment
- (2016) Suthee Rapisuwon et al. Computational and Structural Biotechnology Journal
- Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes
- (2016) Claudia Berrondo et al. PLoS One
- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
- (2015) J. Tie et al. ANNALS OF ONCOLOGY
- Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone
- (2015) S Salvi et al. BRITISH JOURNAL OF CANCER
- Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer
- (2015) A. A. Azad et al. CLINICAL CANCER RESEARCH
- A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer
- (2015) Dipen J. Parekh et al. EUROPEAN UROLOGY
- The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids
- (2015) Marta Fernandez-Mercado et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Circulating Tumor Cell Biomarker Panel As an Individual-Level Surrogate for Survival in Metastatic Castration-Resistant Prostate Cancer
- (2015) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- From hundreds to thousands: Widening the normal human Urinome (1)
- (2015) Laura Santucci et al. Journal of Proteomics
- Urine Aquaporin 1 and Perilipin 2 Differentiate Renal Carcinomas From Other Imaged Renal Masses and Bladder and Prostate Cancer
- (2015) Jeremiah J. Morrissey et al. MAYO CLINIC PROCEEDINGS
- DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence
- (2015) Aaron M. Horning et al. PROSTATE
- Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer
- (2015) Antonin Brisuda et al. UROLOGIA INTERNATIONALIS
- Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer
- (2015) Taku Kato et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1
- (2015) Henriett Butz et al. Oncotarget
- Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel
- (2015) Pedram Kharaziha et al. Oncotarget
- Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma
- (2015) Jeremiah J. Morrissey et al. JAMA Oncology
- Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2015) Emmanuel S. Antonarakis et al. JAMA Oncology
- Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer
- (2015) Francesco Crea et al. Oncotarget
- Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma
- (2015) Nicole M.A. White et al. Oncotarget
- Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer
- (2015) Fubo Wang et al. Oncotarget
- Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer
- (2014) K L Mahon et al. BRITISH JOURNAL OF CANCER
- Identification of Differentially Expressed Long Noncoding RNAs in Bladder Cancer
- (2014) S. Peter et al. CLINICAL CANCER RESEARCH
- Chromosomal Instability in Cell-Free DNA Is a Serum Biomarker for Prostate Cancer
- (2014) E. Schutz et al. CLINICAL CHEMISTRY
- Integrative Bioinformatics Analysis Reveals New Prognostic Biomarkers of Clear Cell Renal Cell Carcinoma
- (2014) H. Butz et al. CLINICAL CHEMISTRY
- Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
- (2014) Sakshi Gulati et al. EUROPEAN UROLOGY
- Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling
- (2014) Yu Fan et al. FEBS Journal
- Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer
- (2014) Amir Goldkorn et al. JOURNAL OF CLINICAL ONCOLOGY
- The End of the Beginning: Circulating Tumor Cells As a Biomarker in Castration-Resistant Prostate Cancer
- (2014) Terence W. Friedlander et al. JOURNAL OF CLINICAL ONCOLOGY
- Liquid chromatography–mass spectrometry based serum peptidomic approach for renal clear cell carcinoma diagnosis
- (2014) Zhenzhen Huang et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Clinical relevance of circulating cell-free microRNAs in cancer
- (2014) Heidi Schwarzenbach et al. Nature Reviews Clinical Oncology
- Massively Parallel Sequencing of Human Urinary Exosome/Microvesicle RNA Reveals a Predominance of Non-Coding RNA
- (2014) Kevin C. Miranda et al. PLoS One
- Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches
- (2014) Clizia Chinello et al. PLoS One
- miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression
- (2014) Claire Corcoran et al. PROSTATE
- Tumor clone dynamics in lethal prostate cancer
- (2014) S. Carreira et al. Science Translational Medicine
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Quantitation of rare circulating tumor cells by folate receptor α ligand-targeted PCR in bladder transitional cell carcinoma and its potential diagnostic significance
- (2014) Fuming Qi et al. TUMOR BIOLOGY
- TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine
- (2013) I. Kinde et al. CANCER RESEARCH
- The Proteomic Revolution in Laboratory Medicine
- (2013) Maria D. Pasic et al. CLINICAL BIOCHEMISTRY
- Genomic Medicine: New Frontiers and New Challenges
- (2013) M. D. Pasic et al. CLINICAL CHEMISTRY
- Quantification of Plasma Cell-Free DNA1in Predicting Therapeutic Efficacy of Sorafenib on Metastatic Clear Cell Renal Cell Carcinoma
- (2013) Gang Feng et al. DISEASE MARKERS
- Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer
- (2013) Elena S. Martens-Uzunova et al. EUROPEAN UROLOGY
- The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients
- (2013) Yahya Elshimali et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics
- (2013) Chien-Lun Chen et al. Journal of Proteomics
- Discovery and validation of urinary biomarkers for detection of renal cell carcinoma
- (2013) Maria Frantzi et al. Journal of Proteomics
- miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis
- (2013) Yun Zhang et al. NATURE CELL BIOLOGY
- Liquid biopsy: monitoring cancer-genetics in the blood
- (2013) Emily Crowley et al. Nature Reviews Clinical Oncology
- MALDI MS profiling of post-DRE urine samples highlights the potential of β-microseminoprotein as a marker for prostatic diseases
- (2013) Brian Flatley et al. PROSTATE
- Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients
- (2013) Ana L. Teixeira et al. TUMOR BIOLOGY
- Monitoring of Plasma Cell-Free DNA in Predicting Postoperative Recurrence of Clear Cell Renal Cell Carcinoma
- (2013) JingJing Wan et al. UROLOGIA INTERNATIONALIS
- B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
- (2013) Xiao Qin et al. OncoTargets and Therapy
- Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
- (2013) Ellen Heitzer et al. Genome Medicine
- Urine Cell-Free DNA Integrity as a Marker for Early Prostate Cancer Diagnosis: A Pilot Study
- (2013) Valentina Casadio et al. Biomed Research International
- MicroRNA 15a, Inversely Correlated to PKCα, Is a Potential Marker to Differentiate between Benign and Malignant Renal Tumors in Biopsy and Urine Samples
- (2012) Melanie von Brandenstein et al. AMERICAN JOURNAL OF PATHOLOGY
- The Long and Winding Road to FDA Approval of a Novel Prostate Cancer Test: Our Story
- (2012) H. Rittenhouse et al. CLINICAL CHEMISTRY
- Circulating Tumor Cells: Liquid Biopsy of Cancer
- (2012) C. Alix-Panabieres et al. CLINICAL CHEMISTRY
- Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study
- (2012) Michael Rink et al. EUROPEAN UROLOGY
- Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma
- (2012) An Zhao et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Comparative and Targeted Proteomic Analyses of Urinary Microparticles from Bladder Cancer and Hernia Patients
- (2012) Chien-Lun Chen et al. JOURNAL OF PROTEOME RESEARCH
- Cell-Free Circulating Plasma hTERT mRNA Is a Useful Marker for Prostate Cancer Diagnosis and Is Associated with Poor Prognosis Tumor Characteristics
- (2012) José A. March-Villalba et al. PLoS One
- Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers
- (2012) Geraldine Perkins et al. PLoS One
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
- (2012) T. Forshew et al. Science Translational Medicine
- Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing
- (2012) R. J. Leary et al. Science Translational Medicine
- Characterization of cell-free circulating DNA in plasma in patients with prostate cancer
- (2012) Pâmela Oliveira Delgado et al. TUMOR BIOLOGY
- Urine Cell-Free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary data
- (2012) Valentina Casadio et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Relaxed imprinting of IGF2 in peripheral blood cells of patients with a history of prostate cancer
- (2012) Djeda Belharazem et al. Endocrine Connections
- Outcomes of Small Renal Mass Needle Core Biopsy, Nondiagnostic Percutaneous Biopsy, and the Role of Repeat Biopsy
- (2011) Michael J. Leveridge et al. EUROPEAN UROLOGY
- Progensa™ PCA3 test for prostate cancer
- (2011) Xavier Durand et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- The Penetration of Renal Mass Biopsy in Daily Practice: A Survey Among Urologists
- (2011) Kurdo Barwari et al. JOURNAL OF ENDOUROLOGY
- Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancer
- (2011) Richard T. Bryan et al. Proteomics Clinical Applications
- Detection of Circulating Tumor Cells in Metastatic and Clinically Localized Urothelial Carcinoma
- (2011) Thomas W. Flaig et al. UROLOGY
- Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients
- (2010) Felix Moltzahn et al. CANCER RESEARCH
- The MicroRNA Spectrum in 12 Body Fluids
- (2010) J. A. Weber et al. CLINICAL CHEMISTRY
- Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors
- (2010) David J. McBride et al. GENES CHROMOSOMES & CANCER
- Discovery of Novel Bladder Cancer Biomarkers by Comparative Urine Proteomics Using iTRAQ Technology
- (2010) Yi-Ting Chen et al. JOURNAL OF PROTEOME RESEARCH
- Circulating Tumor Cells: Will They Be Clinically Useful?
- (2010) N. J. Nelson JNCI-Journal of the National Cancer Institute
- Personalized Medicine: Marking a New Epoch in Cancer Patient Management
- (2010) M. Diamandis et al. MOLECULAR CANCER RESEARCH
- Metastamirs: a stepping stone towards improved cancer management
- (2010) Nicole M. A. White et al. Nature Reviews Clinical Oncology
- Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy
- (2010) Hai-Liang Zhang et al. PROSTATE
- Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non-Small Cell Lung Cancer Patients
- (2009) T. K.F. Yung et al. CLINICAL CANCER RESEARCH
- Prediction of Muscle-invasive Bladder Cancer Using Urinary Proteomics
- (2009) E. Schiffer et al. CLINICAL CANCER RESEARCH
- Multimarker Circulating DNA Assay for Assessing Blood of Prostate Cancer Patients
- (2009) E. Sunami et al. CLINICAL CHEMISTRY
- Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non–Small-Cell Lung Cancer
- (2009) Rafael Rosell et al. Clinical Lung Cancer
- Identification and Validation of the Methylated TWIST1 and NID2 Genes through Real-Time Methylation-Specific Polymerase Chain Reaction Assays for the Noninvasive Detection of Primary Bladder Cancer in Urine Samples
- (2009) Isabelle Renard et al. EUROPEAN UROLOGY
- MicroRNAs in clinical oncology: at the crossroads between promises and problems
- (2009) S M Metias et al. JOURNAL OF CLINICAL PATHOLOGY
- A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer
- (2009) Merle Hanke et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Prediction of Clear Cell Renal Cell Carcinoma by Integrity of Cell-free DNA in Serum
- (2009) Feng Gang et al. UROLOGY
- Diagnostic Role of Circulating Free Plasma DNA Detection in Patients With Localized Prostate Cancer
- (2008) Annalisa Altimari et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
- (2008) Khalid Al-Nedawi et al. NATURE CELL BIOLOGY
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
- Discovery and validation of urinary biomarkers for prostate cancer
- (2008) Dan Theodorescu et al. Proteomics Clinical Applications
- Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators
- (2007) Jörg Ellinger et al. INTERNATIONAL JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now